
### [MONDO:0005072](http://purl.obolibrary.org/obo/MONDO_0005072)
**Label:** neuroblastoma

**Subclasses:** [MONDO:0008380](http://purl.obolibrary.org/obo/MONDO_0008380) (retinoblastoma), [MONDO:0014774](http://purl.obolibrary.org/obo/MONDO_0014774) (neuroblastoma, susceptibility to, 7; NBLST7), [MONDO:0013085](http://purl.obolibrary.org/obo/MONDO_0013085) (NBLST5), [MONDO:0013086](http://purl.obolibrary.org/obo/MONDO_0013086) (NBLST6), [MONDO:0009741](http://purl.obolibrary.org/obo/MONDO_0009741) (neuroblastoma, susceptibility to), [MONDO:0013082](http://purl.obolibrary.org/obo/MONDO_0013082) (Hirschsprung disease-ganglioneuroblastoma syndrome), [MONDO:0013083](http://purl.obolibrary.org/obo/MONDO_0013083) (neuroblastoma, susceptibility to, 3), [MONDO:0013084](http://purl.obolibrary.org/obo/MONDO_0013084) (NBLST4), [MONDO:0018161](http://purl.obolibrary.org/obo/MONDO_0018161) (non-hereditary retinoblastoma), [MONDO:0018160](http://purl.obolibrary.org/obo/MONDO_0018160) (hereditary retinoblastoma), 

**Corr. equiv. classes:** [OMIM:613014](http://purl.obolibrary.org/obo/OMIM_613014), [OMIM:613013](http://purl.obolibrary.org/obo/OMIM_613013), [Orphanet:357027](http://www.orpha.net/ORDO/Orphanet_357027), [OMIM:613016](http://purl.obolibrary.org/obo/OMIM_613016), [OMIM:256700](http://purl.obolibrary.org/obo/OMIM_256700), [OMIM:613015](http://purl.obolibrary.org/obo/OMIM_613015), [Orphanet:790](http://www.orpha.net/ORDO/Orphanet_790), [Orphanet:357034](http://www.orpha.net/ORDO/Orphanet_357034), [OMIM:613017](http://purl.obolibrary.org/obo/OMIM_613017), [Orphanet:2151](http://www.orpha.net/ORDO/Orphanet_2151), [OMIM:180200](http://purl.obolibrary.org/obo/OMIM_180200), [OMIM:616792](http://purl.obolibrary.org/obo/OMIM_616792), 

**Class expressions from DL-Learner:**

- [HP:0006747](http://purl.obolibrary.org/obo/HP_0006747) (Ganglioneuroblastoma) 47.86%
- [HP:0006747](http://purl.obolibrary.org/obo/HP_0006747) (Ganglioneuroblastoma) and [HP:0410008](http://purl.obolibrary.org/obo/HP_0410008) (Abnormality of the peripheral nervous system) 47.86%
- [HP:0006747](http://purl.obolibrary.org/obo/HP_0006747) (Ganglioneuroblastoma) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 47.86%
- [HP:0002270](http://purl.obolibrary.org/obo/HP_0002270) (Abnormality of the autonomic nervous system) and [HP:0006747](http://purl.obolibrary.org/obo/HP_0006747) (Ganglioneuroblastoma) 47.86%
- [HP:0006747](http://purl.obolibrary.org/obo/HP_0006747) (Ganglioneuroblastoma) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0410008](http://purl.obolibrary.org/obo/HP_0410008) (Abnormality of the peripheral nervous system) 47.86%
- [HP:0002270](http://purl.obolibrary.org/obo/HP_0002270) (Abnormality of the autonomic nervous system) and [HP:0006747](http://purl.obolibrary.org/obo/HP_0006747) (Ganglioneuroblastoma) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 47.86%
- [HP:0030063](http://purl.obolibrary.org/obo/HP_0030063) (Neuroepithelial neoplasm) 36.49%
- [HP:0030061](http://purl.obolibrary.org/obo/HP_0030061) (Neuroectodermal neoplasm) 36.34%
- [HP:0030060](http://purl.obolibrary.org/obo/HP_0030060) (Nervous tissue neoplasm) 36.34%
- [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) 27.54%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 24.62%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 24.44%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 21.97%
- Thing 21.97%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 21.97%


